Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
drugs
5
×
medicinal plants
article feedback 5 additional articles
boston blog main
boston top stories
cannabis
cannabis smoking
dissociatives and deliriants
entheogens
euphoriants
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
psychedelics
san diego blog main
san diego top stories
akcea therapeutics
alder biopharmaceutical
allergan
alnylam pharmaceuticals
american academy of neurology
amgen
antiemetics
antioxidants
atogepant
biohaven
biologically based therapies
biotech
bob azelby
boston
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
cannabis culture
clinical trials
What
drug
5
×
make
5
×
marijuana
fda
medical
new
purposes
agency
alcohol
alnylam
approval
approved
approves
arguments
better
big
brain
cannabis
cells
class
closer
commercialized
companies
competitors
dangerous
dea
decades
decentralizes
dependence
discovery
doesn’t
drugs
easier
effect
ema
employ
enforcement
europe
exactly
figured
Language
Current search:
drug
×
make
×
drugs
×
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@theverge.com
7 years ago
Scientists are unlocking the mystery of how marijuana makes us get high
@theverge.com
7 years ago
Medical marijuana doesn’t make for more teenage stoners
@WIRED
7 years ago
The DEA just opened a path for more research into marijuana—and that could make it easier to reschedule the drug.